Targeted expression of MYCN causes neuroblastoma in transgenic mice

EMBO Journal

Volumn 16, Issue 11, 1997, Pages 2985-2995

  Weiss, William A ^a,b   Aldape, Ken ^b   Mohapatra, Gayatry ^b   Feuerstein, Burt G ^b   Bishop, J Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative genomic hybridization; MYCN; N myc; Neuroblastoma; Transgenic

Indexed keywords

NUCLEAR FACTOR I; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; MOUSE; NEUROBLASTOMA; NEUROECTODERM; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ABDOMEN; ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, NEOPLASM; GENE DOSAGE; GENE EXPRESSION; GENE TARGETING; GENES, MYC; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEUROBLASTOMA; NEUROECTODERMAL TUMORS; NUCLEIC ACID HYBRIDIZATION; PROTO-ONCOGENE PROTEINS C-MYC; SPECIES SPECIFICITY; THORAX;

EID: 0030999641     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.11.2985     Document Type: Article

References (45)

1. Aguzzi, A., Wagner, E.F., Williams, R.L. and Courtneidge, S.A. (1990) Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. The New Biologist, 2, 533-543.
2. Banerjee, S.A., Hoppe, P., Brilliant, M. and Chikaraishi, D.M. (1992) 5′ Flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice. J. Neurosci., 12, 4460-4467.
3. Brodeur, G.M. and Castleberry, R.G. (1993) Neuroblastoma. In Pizzo, P.A. and Poplack, D.G. (eds), Principles and Practice of Pediatric Oncology. J.B. Lippincott Co., Philadelphia, PA, pp. 739-767.
4. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. and Bishop, J.M. (1984) Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science, 224, 1121-1124.
5. Caron, H. et al. (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet., 4, 187-190.
6. Cole, C.N. and Stacy, T.P. (1985) Identification of sequences in the herpes simplex virus thymidine kinase gene required for efficient processing and polyadenylation. Mol. Cell. Biol., 5, 2104-2113.
7. Copeland, N.G. et al. (1993) A genetic linkage map of the mouse: current applications and future prospects. Science, 262, 57-67.
8. Dildrop, R., Ma, A., Zimmerman, K., Hsu, A., Tesfaye, A., DePinho, R. and Alt, F.W. (1989) IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J., 8, 1121-1128.
9. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 356, 215-221.
10. Fong, C.T. et al. (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res., 52, 1780-1785.
11. Galaktionov, K., Chen, X. and Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
12. Hogan, B., Beddington, R., Costantini, F. and Lacy, E. (1994) Manipulation of the Mouse Embryo: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 173-178; 244-248.
13. Hosoi, G., Hara, J., Okamura, T., Osugi, Y., Ishihara, S., Fukuzawa, M., Okada, A., Okada, S. and Tawa, A. (1994) Low frequency of the p53 gene mutations in neuroblastoma. Cancer, 73, 3087-3093.
14. Imamura, J., Bartram, C.R., Berthold, F., Harms, D., Nakamura, H. and Koeffler, H.P. (1993) Mutation of the p53 gene in neuroblastoma and its relationship with MYCN amplification. Cancer Res., 53, 4053-4058.
15. Iwamoto, T., Taniguchi, M., Wajjwalku, W., Nakashima, I. and Takahashi, M. (1993) Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene. Br. J. Cancer, 67, 504-507.
16. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A. and Weinberg, R.A. (1992) Effects of an Rb mutation in the mouse. Nature, 359, 295-300.
17. Jacks, T., Shih, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A. and Weinberg, R.A. (1994) Tumor predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet., 7, 353-361.
18. Johnson, M.R., Look, A.T., DeClue, J.E., Valentine, M.B. and Lowy, D.R. (1993) Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP·Ras. Proc. Natl Acad. Sci. USA, 90, 5539-5543.
19. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
20. Kohl, N.E., Kanda, N., Schreck, R.R., Bruns, G., Latt, S.A., Gilbert, F. and Alt, F.W. (1983) Transposition and amplification of oncogene related sequences in human neuroblastomas. Cell, 35, 359-367.
21. Kohl, N.E., Gee, C.E. and Alt, F.W. (1984) Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science, 226, 1335-1337.
22. Koike, K., Jay, G., Hartley, J. Schrenzel, M.D., Higgins, R.J. and Hinrichs, S.H. (1990) Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastoma. J. Virol., 64, 3988-3991.
23. Manohar, C.F., Salwen, H.R., Brodeur, G.M. and Cohn, S.L. (1995) Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes, Chromosomes Cancer, 14, 196-203.
24. Marthay, K.K. (1995) Neuroblastoma: a clinical challenge and biologic puzzle. Ca, Cancer J. Clin., 45, 179-192.
25. Mohapatra, G., Kim, D.H. and Feuerstein, B.G. (1995) Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes, Chromosomes Cancer, 13, 86-93.
26. Mouse Genome Database (MGD), Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, ME. World Wide Web (URL: http:// www.informatics.jax.org/). 12/16/96).
27. Nakagawara, A., Toyohara, T., Nada, O. and Ikeda, K. (1986) Catecholaminergic differentiation associated with S100 protein-positive elements in human neuroblastoma. Z. Kinderchir., 41, 275-278.
28. Nakamura, T., Iwamura, Y., Kaneko, M., Nakagawa, K., Kawai, K., Mitamura, K. Futagawa, T. and Hayashi, H. (1991) Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors. Jap. J. Clin. Oncol., 21, 325-329.
29. Nusse, R., van Ooyen, A., Cox, D., Fung, Y.K. and Varmus, H. (1984) Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature, 307, 131-136.
30. O'Hare, K., Benoist, C. and Breathnach, R. (1981) Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc. Natl Acad. Sci. USA, 78, 1527-1531.
31. Piper, J., Rutovitz, D., Sudar, D., Kallioniemi, A., Kallioniemi, O.P., Waldman, F.M., Gray, J.W. and Pinkel, D. (1995) Computer image analysis of comparative genomic hybridization. Cytometry, 19, 10-26.
32. Plantaz, D., Mohapatra, G., Matthay, K.K., Pellarin, M., Seeger, R.C and Feuerstein, B.G. (1997) Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am. J. Pathol., 150, 81-89.
33. Ramsay, G., Stanton, L., Schwab, M. and Bishop, J.M. (1986) Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol. Cell. Biol., 6, 4450-4457.
34. Reiter, J.L. and Brodeur, G.M. (1996) High resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Genomics, 32, 97-103.
35. Rosenbaum, H., Webb, E., Adams, J.M., Cory, S. and Harris, A.W. (1989) N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J., 8, 749-755.
36. Schwab, M., Alitalo, K., Klempnauer, K.H., Varmus, H.E., Bishop, J.M., Gilbert, F., Brodeur, G., Goldstein, M. and Trent, J. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature, 305, 245-248.
37. Schwab, M., Varmus, H.E. and Bishop, J.M. (1985) The human N-myc gene contributes to tumorigenic conversion of mammalian cells in culture. Nature, 316, 160-162.
38. Skalnik, D.G., Dorfman, D.M., Williams, D.A. and Orkin, S.H. (1991) Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol. Cell. Biol., 11, 4518-4527.
39. Small, J.A., Khoury, G., Jay, G., Howley, P. and Scangos, G. (1986) Early regions of JC and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc. Natl Acad. Sci. USA, 83, 8288-8292.
40. Small, M., Hay, N., Schwab, M. and Bishop, J.M. (1987) Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol., 7, 1638-1645.
41. The, I, Murthy, A.E., Hannigan, G.E., Jacoby, L.B., Menon, A,G., Gusella, J.F. and Bernards, A. (1993) Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet., 3, 62-66.
42. Tlsty, T.D. (1990) Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl Acad. Sci. USA, 87, 3132-3136.
43. Weith, A., Martinsson, T., Cziepluch, C., Bruderlein, S., Amler, L.C., Berthold, F. and Schwab, M. (1989) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes, Chromosomes Cancer, 1, 159-166.
44. White, P.S. et al. (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc. Natl Acad. Sci. USA, 92, 5520-5524.
45. Wright, J.A., Smith, H.S., Watt, F.M., Hancock, M.C., Hudson, D.L. and Stark, G.R. (1990) DNA amplification is rare in normal human cells. Proc. Natl Acad. Sci. USA, 87, 1791-1795.